
Citation: Kasbawati, Mariani, Nur Erawaty, Naimah Aris. A mathematical study of effects of delays arising from the interaction of anti-drug antibody and therapeutic protein in the immune response system[J]. AIMS Mathematics, 2020, 5(6): 7191-7213. doi: 10.3934/math.2020460
[1] | Rosalie Allison, Emma L. Bird, Stuart McClean . Is Team Sport the Key to Getting Everybody Active, Every Day? A Systematic Review of Physical Activity Interventions Aimed at Increasing Girls’ Participation in Team Sport. AIMS Public Health, 2017, 4(2): 202-220. doi: 10.3934/publichealth.2017.2.202 |
[2] | Alexios Batrakoulis, Oscar L Veiga, Susana Franco, Ewan Thomas, Antonios Alexopoulos, Manel Valcarce-Torrente, Rita Santos-Rocha, Fatima Ramalho, Andrea Di Credico, Daniela Vitucci, Liliana Ramos, Vera Simões, Alejandro Romero-Caballero, Isabel Vieira, Annamaria Mancini, Antonino Bianco . Health and fitness trends in Southern Europe for 2023: A cross-sectional survey. AIMS Public Health, 2023, 10(2): 378-408. doi: 10.3934/publichealth.2023028 |
[3] | Clemens Drenowatz, Gerson Ferrari, Carla Greier, Gerhard Ruedl, Klaus Greier . Perceived importance of and attitude towards physical education in Austrian adolescents – The role of sex, age and weight status. AIMS Public Health, 2025, 12(2): 520-535. doi: 10.3934/publichealth.2025028 |
[4] | Joram Weber, Claudio R. Nigg . Promoting fruit and vegetable consumption during the COVID-19 pandemic – SportStudisMoveYou (SSMY): A randomized controlled trial. AIMS Public Health, 2022, 9(4): 690-702. doi: 10.3934/publichealth.2022048 |
[5] | Sonia Lippke, Luisa Korte, Vinayak Anand Kumar, Andreas Fach, Tiara Ratz . Health behavior and disease self-management indicators in patients with cardiovascular diseases using a health app: Findings from an RCT. AIMS Public Health, 2025, 12(1): 233-258. doi: 10.3934/publichealth.2025015 |
[6] | Naime Altay, Ebru Kılıcarslan Toruner, Ebru Akgun-CITAK . Determine the BMI levels, self-concept and healthy life behaviours of children during a school based obesity training programme. AIMS Public Health, 2020, 7(3): 535-547. doi: 10.3934/publichealth.2020043 |
[7] | Michael O Ogundele, Hani F Ayyash . ADHD in children and adolescents: Review of current practice of non-pharmacological and behavioural management. AIMS Public Health, 2023, 10(1): 35-51. doi: 10.3934/publichealth.2023004 |
[8] | Emmelie Barenfeld, Synneve Dahlin-Ivanoff, Lars Wallin, Susanne Gustafsson . Promoting aging migrants’ capabilities: A randomized controlled trial concerning activities of daily living and self-rated health. AIMS Public Health, 2018, 5(2): 173-188. doi: 10.3934/publichealth.2018.2.173 |
[9] | Amir A. Hadi Alakaam, Jennifer L. Lemacks . Fruit and Vegetable Consumption, Fat Intake, and Physical Activity Participation in Relation to Socio-demographic Factors Among Medically Underserved Adults. AIMS Public Health, 2015, 2(3): 402-410. doi: 10.3934/publichealth.2015.3.402 |
[10] | Andrew Brinkley, Josie Freeman, Hilary McDermott, Fehmidah Munir . What are the Facilitators and Obstacles to Participation in Workplace Team Sport? A Qualitative Study. AIMS Public Health, 2017, 4(1): 94-126. doi: 10.3934/publichealth.2017.1.94 |
In the field of biomathematics, the predator-prey model has been studied by many scholars. They explored the dynamical behavior among biological populations by establishing differential equations [1,2,3,4]. In 1925, the Lotka-Volterra model described the variation in population size between predator and prey in [5,6]. This model describes that population size changes are interacting. After that, in order to study the situation that predator populations have other food sources besides prey population, Leslie and Gower [7,8] proposed a Leslie-Gower type predator-prey model. This model mainly explores the fact that when the preferred food decreases, the number of predators also decreases. Then Aziz-Alaoui and Okiye added a constant to the denominator of the Leslie-Gower type functional response function in [9], calling it the modified Leslie-Gower type. This type limits the growth of predators due to severe shortages of preferred foods, despite the predators having other food sources. Besides, the impact of infectious diseases on populations in nature is also important. In order to study the dynamical behavior of populations in more complex situations, some factors influencing population size changes have been added to the Leslie-Gower type model. The authors of [10] describe the mechanism of disease transmission by using the Holling type Ⅱ. Some scholars have included disease factors in their studies of fractional differential equations as well, e.g., [11,12,13,14].
However, in nature, biological populations are inevitably impacted by environment noise more or less. During the past decades, many investigators have focused on the study of stochastic biological models [15,16]. Among them, a predator-prey-parasite model with stochastic perturbations has been studied by Majumder et al. [17]. Parasitic infections divide prey populations into susceptible and infected populations, and infected populations lose fertility and do not heal again. Both susceptible and infected prey populations are preyed upon by predators, and the predators will not be infected by the disease. They constructed the following model:
{dx(t)=[ax(t)−bx2(t)−λx(t)y(t)−cx(t)z(t)m1+x(t)+y(t)]dt+σ1x(t)dB1(t),dy(t)=[λx(t)y(t)−my2(t)−ey(t)z(t)m1+x(t)+y(t)−γy(t)]dt+σ2y(t)dB2(t),dz(t)=[rz(t)−fz2(t)m2+x(t)+y(t)]dt+σ3z(t)dB3(t), |
where x(0)≥0, y(0)≥0, z(0)≥0.
In addition, the fear of predators can also influence the birth rates and offspring survival of prey populations. Zanette et al. [18] verified this idea through experiments. It is noted in [19] that the mental state of juvenile prey can be mediated by predator-induced fear and this fear may have an impact on their survival rates as adults. Thus, many scholars have realized that the fear costs of predators can directly or indirectly affect the prey population. So it should be included in the predator-prey system. Based on this view, scholars have studied the fear effect of biological populations [20,21]. Qi and Meng [22] used (θ+K(1−θ)K+z(t)) to represent the fear function to measure the cost of fear. θ∈[0,1] represents the cost of minimum fear and K represents the level of prey fear of predator populations. Let κ(θ,K,z)=θ+K(1−θ)K+z; we have ∂κ(θ,K,z)∂z<0. From this, it is clear that the larger the predator population, the stronger the inhibitory effect on the growth of the prey population. Therefore, introducing a fear factor into the prey-predator system can help us to explore the variation of populations in different situations better.
In addition, natural species may be subjected to unexpected environmental disruptions such as epidemics, hurricanes, earthquakes and so on. Random perturbations described by Brownian can only characterize the continuous influence, but it does not describe sudden and drastic environmental changes very well. To explain this occurrence, Bao et al. included Lévy jumps into population models in [23,24]. Wu and Wang [25] considered the population dynamical behaviors of stochastic system with jumps. So we also want to introduce Lévy jumps into a stochastic predator-prey model.
Inspired by the articles above, we consider adding a fear factor to susceptible prey populations and considered more complex diseases, using the Holling type Ⅱ function to represent the spread of disease. Finally, we use Lévy noise to describe the situation when the population is subjected to drastic changes from the outside. We consider the following stochastic disease including predator-prey model with Lévy noise and fear effects:
{dx(t)=x(t)[r(θ+K(1−θ)K+z(t))−bx(t)−az(t)1+b1(x(t)+y(t))+b2z(t)−ηy(t)b3+x(t)]dt+σ1x(t)dB1(t)+∫Γx(t−)γ1(u)˜N(du,dt),dy(t)=y(t)[ηx(t)b3+x(t)−cy(t)−dz(t)1+b1(x(t)+y(t))+b2z(t)−γ]dt+σ2y(t)dB2(t)+∫Γy(t−)γ2(u)˜N(du,dt),dz(t)=z(t)[β−gz(t)m+x(t)+y(t)]dt+σ3z(t)dB3(t)+∫Γz(t−)γ3(u)˜N(du,dt), | (1.1) |
with initial values x(0)=x0, y(0)=y0 and z(0)=z0. In this model, x(t), y(t) and z(t) denote the population densities of the susceptible prey, infected prey and predator population at time t respectively. And the per capita maximum fertility rates of the prey and predator populations are written as r and β respectively; the intensity of interspecific competition in prey populations is denoted by b and c; η represents the disease transmission rate and ηx(t)y(t)b3+x(t) describes the spread of the disease; a and d are the consumption rates and γ is the death rate of the infected prey population. g represents the interspecific competition of predators and m is the half-saturation constant of predators. b1 and b2 represent the prey saturation constants and predator disturbance respectively. There are no negative constants among any of the parameter values.
Bi(t) (i=1,2,3) represents Brownian motion, and each value is independent of each other. In addition, there is a complete probability space (Ω,F,{Ft}t≥0,P) with a filtration {Ft}t≥0 that meets the normal requirements, and Bi(t) (i=1,2,3) is defined on this probability space. σ2i (i=1,2,3) represents the noise's level of intensity. The left limits of x(t), y(t) and z(t) are represented by x(t−), y(t−) and z(t−) respectively. N(dt,du) is a Poisson counting measure which is defined on λ(du). The characteristic measure λ on the measure subset Γ of [0,+∞] such that λ(Γ)<∞. N(dt,du) is defined on R+×(R−{0}), R+:=(0,∞). Besides, ˜N(dt,du)=N(dt,du)−λ(du)dt is the corresponding martingale measure. γi(u) (i=1,2,3) measures the effect of a Lévy jump on prey and predator populations, γi(u)>−1 (i=1,2,3) for u∈Γ. In addition, it is important to note that Lévy jumps have a facilitating effect on the ecosystem when γi>0 (i=1,2,3), such as an ocean red tide. When γi<0 (i=1,2,3), Lévy jumps have a negative effect on the ecosystem, such as tsunamis and earthquakes. See [26,27] for specific examples.
In this article, we need to assume that the coefficients satisfy the following assumption:
Assumption 1. There exists a positive constant K which gives:
∫Γ[ln(1+γi(u))]2λ(du)<K, ∫Γγ2i(u)λ(du)<K, i=1,2,3. |
It means that the intensity of Lévy noise is not very large. Here are some inequalities we will frequently use:
lnp≤p−1, p>0; pr≤1+r(p−1), p≥0, 1≥r≥0. |
Lemma 1. ([28]) Denote by Σ(t) a local martingle vanishing at t=0. Define
¯Σ(t)=∫t0d⟨Σ⟩(s)(1+s)2dt, t≥0, |
where ⟨Σ⟩(t)=⟨Σ,Σ⟩(t) stands for the Meyer's angle bracket process. If lim supt→+∞¯Σ(t)<+∞, then limt→+∞t−1Σ(t)=0, a.s.
The rest of the research for this paper is as follows. In Section 2, we present the existence and uniqueness of the positive solution of System (1.1). In Section 3, we first studied the conditions for population extinction. Then we considered the existence and extinction of susceptible prey populations and predator populations under conditions where the disease is effectively prevented and infected prey populations are extinct. In Section 4, it proves the stochastic ultimate boundedness of System (1.1) and the existence of ergodic stationary distribution of the System (1.1) when Lévy noise does not exist. In Section 5, we select suitable parameters and use numerical simulations to prove our conclusions. Lastly, we briefly summarize the work of article.
In order to study the dynamical behavior of the system, we first verify that there is a globally unique positive solution for System (1.1). First, we give Lemma 2 to show that the positive solution of the system exists locally and uniquely, and then prove that the solution exists globally with Theorem 1.
Lemma 2. For any given initial value (x0,y0,z0)∈R3+, there exists a unique local positive solution (x(t),y(t),z(t)) to System (1.1), as defined on the interval t∈[0,τe), where τe is the explosion time.
Proof. Consider the equation
{dN1(t)=dlnx(t)=[r(θ+K(1−θ)K+eN3(t))−beN1(t)−aeN3(t)1+b1(eN1(t)+eN2(t))+b2eN3−ηeN2(t)b3+eN1(t)−σ212+∫Γ[ln(1+γ1(u))−γ1(u)]λ(du)]dt+σ1dB1(t)+∫Γln(1+γ1(u))˜N(dt,du),dN2(t)=dlny(t)=[ηeN1(t)b3+eN1(t)−ceN2(t)−deN3(t)1+b1(eN1(t)+eN2(t))+b2eN3(t)−γ−σ222+∫Γ[ln(1+γ2(u))−γ2(u)]λ(du)]dt+σ2dB2(t)+∫Γln(1+γ2(u))˜N(dt,du),dN3(t)=dlnz(t)=[β−geN3(t)m+eN1(t)+eN2(t)−σ232+∫Γ[ln(1+γ3(u))−γ3(u)]λ(du)]dt+σ3dB3(t)+∫Γln(1+γ3(u))˜N(dt,du), |
with initial values N1(0)=lnx0, N2(0)=lny0 and N3(0)=lnz0 on t≥0. It is easy to see that the above equation satisfies the local Lipschitz condition. Therefore, System (1.1) has a unique local solution (N1(t),N2(t),N3(t)) for t∈[0,τe), and τe is the explosion time. Because x(t)=eN1(t), y(t)=eN2(t) and z(t)=eN3(t), by Itô's formula, we get that (x(t),y(t),z(t)) is the unique local positive solution to System (1.1) with the initial value (x0,y0,z0).
Theorem 1. For any given initial value (x0,y0,z0)∈R3+, a unique global positive solution (x(t),y(t),z(t)) exists in System (1.1) for ∀t∈[0,+∞).
Proof. In order to prove that the solution is global, we need to prove τe=∞ a.s. Let m0>0 be sufficiently large to make x0,y0,z0∈[1m0,m0] for each integer m≥m0; then, define the stopping time
τm=inf{t∈[0,τe):min{x(t),y(t),z(t)}≤1m or max{x(t),y(t),z(t)}≥m}. |
Let inf∅=∞ (∅ refers to the empty set). Obviously, as m tends to infinity, τm is increasing. Let τ∞=limm→∞τm and τ∞≤τe, a.s. If we can prove τ∞=∞ a.s. then we have τe=∞ a.s., for all t≥0.
We can proof by contradiction. If not, there exists a pair constants T≥0 and ε∈(0,1) such that P(τ∞≤T)>ε. Thus ∃ m1≥m0, we have
P(τm≤T)≥ε for all m≥m1. |
Define a C2-function V: R3+→R+
V(x,y,z)=(x−1−lnx)+(y−1−lny)+(z−1−lnz). |
Because s−1−lns>0, for all s>0, we have V(x,y,z)>0. Applying Itô's formula, the following equation yields
dV(x,y,z)=LV(x,y,z)dt+σ1(x−1)dB1(t)+σ2(y−1)dB2(t)+σ3(z−1)dB3(t)+∫Γ[x(t−)γ1(u)−ln(1+γ1(u))]˜N(dt,du)+∫Γ[y(t−)γ2(u)−ln(1+γ2(u))]˜N(dt,du)+∫Γ[z(t−)γ3(u)−ln(1+γ3(u))]˜N(dt,du); | (2.1) |
LV:R3+→R+ is given as follows and using Assumption 1, we obtain
LV(x,y,z)=rx(θ+K(1−θ)K+z)−bx2−axz1+b1(x+y)+b2z−ηxyb3+x−r(θ+K(1−θ)K+z)+bx+az1+b1(x+y)+b2z+ηyb3+x+σ21+σ22+σ232+ηxyb3+x−cy2−dyz1+b1(x+y)+b2z−γy−ηxb3+x+cy+dz1+b1(x+y)+b2z+γ+βz−gz2m+x+y−β+gzm+x+y+∫Γ[γ1(u)−ln(1+γ1(u))]λ(du)+∫Γ[γ2(u)−ln(1+γ2(u))]λ(du)+∫Γ[γ3(u)−ln(1+γ3(u))]λ(du)≤rx−bx2+bx+ab2+ηy−cy2+cy+db2+γ+βz+gz≤M+(β+g)z, |
where
M=sup{−bx2+(r+b)x+ab2−cy2+(η+c)y+db2+γ+σ21+σ22+σ312+∫Γ[γ1(u)−ln(1+γ1(u))]λ(du)+∫Γ[γ2(u)−ln(1+γ2(u))]λ(du)+∫Γ[γ3(u)−ln(1+γ3(u))]λ(du)} | (2.2) |
is a positive constant.
We have that z≤2(z−1−lnz)+ln4≤2V(x,y,z)+ln4. We can write:
LV(x,y,z)≤M+(β+g)ln4+2(β+g)V(x,y,z)≤M1(1+V(x,y,z)), | (2.3) |
where M1=max{M+(β+g)ln4,2(β+g)}.
Combining (2.1) and (2.3), we can obtain that
dV(x,y,z)≤M1(1+V(x,y))dt+σ1(x−1)dB1(t)+σ2(y−1)dB2(t)+σ3(z−1)dB3(t)+∫Γ[x(t−)γ1(u)−ln(1+γ1(u))]˜N(dt,du)+∫Γ[y(t−)γ2(u)−ln(1+γ2(u))]˜N(dt,du)+∫Γ[z(t−)γ3(u)−ln(1+γ3(u))]˜N(dt,du). | (2.4) |
The integration is taken at both ends of the inequality (2.4) from 0 to τm∧T, followed by the expectation, yielding
EV(x(τm∧T),y(τm∧T)),z(τm∧T))≤V(x0,y0,z0)+M1E∫τm∧T0(1+V(x,y,z))dt≤V(x0,y0,z0)+M1E∫T0V(x(t),y(t),z(t))dt+M1T≤V(x0,y0,z0)+G1∫T0EV(x(t),y(t),z(t))dt+M1T. |
By Gronwall's inequality, we can get
EV(x(τm∧T),y(τm∧T),z(τm∧T))≤(V(x0,y0,z0)+M1T)eM1T. |
Let Ωm=τm≤T; we have P(Ωm)≥ε. So for ∀ω∈Ωm, at least one value of x(τm,ω), y(τm,ω) or z(τm,ω) equals either m or 1m. Note that V(x(τm),y(τm),z(τm)) is no less than (m−1−lnm)∧(1m−1−ln1m). Consequently,
(V(x0,y0,z0)+M1T)eM1T≥E(1Ωm(ω),V(x(τm),y(τm),z(τm)))≥ε(m−1−lnm)∧(1m−1−ln1m), |
where 1Ωm(ω) is the indicator function of ωm. Then, let m→∞; we deduce that
ε(m−1−lnm)∧(1m−1−ln1m)→+∞; |
this is contradictory. Hence, we can get τ∞=∞.
The result is confirmed.
In this section, we consider the long time behavior of System (1.1). The conditions when the susceptible prey population, the infected prey population and the predator population are all extinct are first considered. Then we explore the existence and extinction of susceptible prey populations and predator populations in the context of the effective prevention of infectious disease.
Theorem 2. For any given initial value (x0,y0,z0)∈R3+, the solution (x(t),y(t),z(t)) of system (1.1) has the following properties if Assumption 1 holds:
r(θ+K(1−θ))−σ212−∫Γ[γ1(u)−ln(1+γ1(u))]λ(du)<0,η−σ222−∫Γ[γ2(u)−ln(1+γ2(u))]λ(du)<0,β−σ232−∫Γ[γ3(u)−ln(1+γ3(u))]λ(du)<0; |
then the predator and prey populations will be extinctive almost surely, that is
limt→∞x(t)=0, limt→∞y(t)=0, limt→∞z(t)=0. | (3.1) |
Proof. First of all, we consider the prey population. We have d{etlnx(t)}=etdlnx(t)+etlnx(t) and the fundamental inequality lnx≤x−1 for all x>0. Calculating by Itô's formula, we get
dlnx(t)=[r(θ+K(1−θ)K+z)−bx−az1+b1(x+y)+b2z−ηyb3+x−σ212−∫Γ[γ1(u)−ln(1+γ1(u))]λ(du)]dt+σ1dB1(t)+∫Γln(1+γ1(u))˜N(du,dt)≤[r(θ+K(1−θ))−σ212−∫Γ[γ1(u)−ln(1+γ1(u))]λ(du)]dt+σ1dB1(t)+∫Γln(1+γ1(u))˜N(du,dt). |
Integrating both sides of the above inequality simultaneously, we have
lnx(t)≤lnx0+∫t0[r(θ+K(1−θ))−σ212−∫Γ[γ1(u)−ln(1+γ1(u))]λ(du)]ds+∫t0σ1dB(s)+∫t0∫Γln(1+γ1(u))˜N(du,ds). |
Then, we have
lnx(t)t≤[r(θ+K(1−θ))−σ212−∫Γ[γ1(u)−ln(1+γ1(u))]λ(du)]+∫t0σ1dB1(s)t+Σ1(t)t+lnz0t. | (3.2) |
Denote Σ1(t)=∫t0∫Γln(1+γ1(u))˜N(ds,du); in light of Assumption 1,
⟨Σ1,Σ1⟩(t)=t∫Γ[ln(1+α(x))]2λ(du)<Ft, |
where F is a positive number. So we have ∫t0F(1+s)2ds=tt+1<∞; then, it follows from Lemma 2 that
limt→∞t−1Σ1(t)=0, a.s. | (3.3) |
Taking the limit on both sides of the inequality (3.2) and bringing in (3.3), we get
lim supt→∞lnx(t)t≤limt→∞[r(θ+K(1−θ))−σ212−∫Γ[γ1(u)−ln(1+γ1(u))]λ(du)+∫t0σ1dB1(s)t+Σ1(t)t+lnz0t]=r(θ+K(1−θ))−σ212−∫Γ[γ1(u)−ln(1+γ1(u))]λ(du). |
When r(θ+K(1−θ))−σ212−∫Γ[γ1(u)−ln(1+γ1(u))]λ(du)<0, the susceptible prey population will be extinct.
Similarly, for the infected prey and predator populations, we have
lim supt→∞lny(t)t≤η−σ222−∫Γ[γ2(u)−ln(1+γ2(u))]λ(du), |
lim supt→∞lnz(t)t≤β−σ232−∫Γ[γ3(u)−ln(1+γ3(u))]λ(du). |
When η−σ222−∫Γ[γ2(u)−ln(1+γ2(u))]λ(du)<0 and β−σ232−∫Γ[γ3(u)−ln(1+γ3(u))]λ(du)<0, the infected prey and predator population will be extinct.
The result is confirmed.
In this section, we expect that infectious diseases transmitted among prey populations will be effectively prevented, susceptible prey populations will no longer be infected and infected prey populations will gradually die out. Considering the extinction of the infected population under the condition that η−σ222−∫Γ[γ2(u)−ln(1+γ2(u))]λ(du)<0, i.e., after the infectious disease is cured, we have limt→∞y(t)=0. For ∀ε>0, there exist t1 and a set Ωε such that P(Ωε)≥1−ε and ηx(t)y(t)b3+x(t)<ε; for t1≤t and ω∈Ωε. Therefore, we next focused on the changes in susceptible and predator populations when infected prey populations perished.
Definition 1. ([29]) The susceptible prey populations and predator populations are said to be persistent in mean if
lim inft→∞1t∫t0x(s)ds>0 a.s., lim inft→∞1t∫t0y(s)ds>0 a.s. |
Lemma 3. ([30]) Let b(t)∈C(Ω×[0,+∞),R+)
1) If there exist two positive constants T and v0 such that lnb(t)≤vt−v0∫t0b(s)ds+σB(t) for ∀t≥T, where σ>0, then
{lim supt→∞1t∫t0b(s)ds≤vv0, if v≥0,limt→∞b(t)=0, if v<0. |
2) If there exist two positive constants T and v0 such that lnb(t)≥vt−v0∫t0b(s)ds+σB(t) for ∀t≥T, where σ>0, then
lim inft→∞1t∫t0b(s)ds≥vv0. |
Theorem 3. Suppose that (x(t),y(t),z(t)) denotes the positive solution to System (1.1) with the initial positive value (x0,y0,z0)>0; when infected prey populations tend to become extinct, that is, limt→∞y(t)=0, we have the following
(A1). If r<σ212−∫Γ[γ1(u)−ln(1+γ1(u))]λ(du), β>σ232−∫Γ[γ3(u)−ln(1+γ3(u))]λ(du), then the predator is persistent in mean and the susceptible prey is extinct, that is
limt→∞x(t)=0 andlimt→∞t−1∫t0z(s)ds=mg(β−σ232−∫Γ[γ3(u)−ln(1+γ3(u))]λ(du)). |
(A2). If 1b(rθ2−ab2−σ212−∫Γ[γ1(u)−ln(1+γ1(u))]λ(du))>0 and β<σ232−∫Γ[γ3(u)−ln(1+γ3(u))]λ(du), then the susceptible prey is persistent in mean and the predator is extinct, that is
limt→∞z(t)=0 andlim inft→∞t−1∫t0x(s)ds≥1b(rθ2−ab2−σ212−∫Γ[γ1(u)−ln(1+γ1(u))]λ(du))>0. |
(A3). If 1b(rθ2−ab2−σ212−∫Γ[γ1(u)−ln(1+γ1(u))]λ(du))>0 and β>σ232−∫Γ[γ3(u)−ln(1+γ3(u))]λ(du), then both the susceptible prey and predator are persistent in mean, that is
lim inft→∞t−1∫t0x(s)ds≥1b(rθ2−ab2−σ212−∫Γ[γ1(u)−ln(1+γ1(u))]λ(du))>0 andlim inft→∞t−1∫t0z(s)ds≥mg(β−σ232−∫Γ[γ3(u)−ln(1+γ3(u))]λ(du))>0. |
Proof. According to Theorem 2, when η−σ222−∫Γ[γ2(u)−ln(1+γ2(u))]λ(du)<0, limt→+∞y(t)=0. So we know that ∃ε2>0 for ∀T2>0 when t>T2 such that 0<y(t)≤ε2.
(A1) Similarly, when limt→+∞x(t)=0, we know that ∃ε1>0 for ∀T1>0 when t>T1 such that 0<x(t)≤ε1. We obtain
dlnz(t)≤(β−σ232−gz(t)m+ε1+ε2−∫Γ[γ3(u)−ln(1+γ3(u))]λ(du))dt+σ3B3(t)+∫Γln(1+γ3(u))˜N(du,dt). |
Integrating both sides of the above formula, we have
lnz(t)−lnz(0)≤(β−σ232−∫Γ[γ3(u)−ln(1+γ3(u))]λ(du))t−gm+ε1+ε2∫t0z(s)ds+∫t0σ3B3(t)+∫t0∫Γln(1+γ3(u))˜N(du,ds). | (3.4) |
Similarly, we have
lnz(t)−lnz(0)≥(β−σ232−∫Γ[γ3(u)−ln(1+γ3(u))]λ(du))t−gm∫t0z(s)ds+∫t0σ3B3(s)+∫t0∫Γln(1+γ3(u))˜N(du,ds). | (3.5) |
Applying Lemma 3 and Assumption 1 to (3.4) and (3.5) respectively, we have
0<mg(β−σ232−∫Γ[γ3(u)−ln(1+γ3(u))]λ(du))≤lim inft→∞t−1∫t0z(s)ds≤lim supt→∞t−1∫t0z(s)ds≤(m+ε1+ε2)g(β−σ232−∫Γ[γ3(u)−ln(1+γ3(u))]λ(du)). | (3.6) |
For ∀ε1,ε2, we can obtain
limt→∞t−1∫t0z(s)ds=mg(β−σ232−∫Γ[γ3(u)−ln(1+γ3(u))]λ(du)). | (3.7) |
(A2) When β−σ232−∫Γ[γ3(u)−ln(1+γ3(u))]λ(du)<0, z(t) comes to extinct, limt→∞z(t)=0. By Itô's formula, we have
dlnx(t)≤[r(θ+K(1−θ))−bx−σ212−∫Γ[γ1(u)−ln(1+γ1(u))]λ(du)]dt+σ1dB1(t)+∫Γln(1+γ1(u))˜N(du,dt) | (3.8) |
and
dlnx(t)≥[rθ−bx−ab2−ηε2−σ212−∫Γ[γ1(u)−ln(1+γ1(u))]λ(du)]dt+σ1dB1(t)+∫Γln(1+γ1(u))˜N(du,dt). | (3.9) |
Integrating both sides of (3.8) and (3.9) from 0 to t and letting ηε2=rθ2, we obtain
lnx(t)−lnx(0)≤[r(θ+K(1−θ))−σ212−∫Γ[γ1(u)−ln(1+γ1(u))]λ(du)]t−b∫t0x(s)ds+∫t0σ1dB1(s)+∫t0∫Γln(1+γ1(u))˜N(du,ds) |
and
lnx(t)−lnx(0)≥[rθ−ab2−rθ2−σ212−∫Γ[γ1(u)−ln(1+γ1(u))]λ(du)]t−b∫t0x(s)ds+∫t0σ1dB1(s)+∫t0∫Γln(1+γ1(u))˜N(du,ds). |
Similar to (A1), by Lemma 3 and Assumption 1, we can get
1b(rθ2−ab2−σ212−∫Γ[γ1(u)−ln(1+γ1(u))]λ(du))≤lim inft→∞t−1∫t0x(s)ds≤lim supt→∞t−1∫t0x(s)ds≤1b(r(θ+K(1−θ))−σ212−∫Γ[γ1(u)−ln(1+γ1(u))]λ(du)). |
(A3) From (3.5), we can deduce that
lim inft→∞t−1∫t0z(s)ds≥mg(β−σ232−∫Γ[γ3(u)−ln(1+γ3(u))]λ(du))>0. |
The conclusion is confirmed.
Moreover, when γi(u)=0 (i=1,2,3), this means that the population will not suffer drastic environmental changes. So, System (1.1) produces the following system:
{dx(t)=[rx(t)(θ+K(1−θ)K+z(t))−bx2(t)−ax(t)z(t)1+b1(x(t)+y(t))+b2z(t)−ηx(t)y(t)b3+x(t)]dt+σ1x(t)dB1(t),dy(t)=[ηx(t)y(t)b3+x(t)−cy2(t)−dy(t)z(t)1+b1(x(t)+y(t))+b2z(t)−γy(t)]dt+σ2y(t)dB2(t),dz(t)=[βz(t)−gz2(t)m+x(t)+y(t)]dt+σ3z(t)dB3(t). | (4.1) |
In this part, we solve the stochastically ultimately bounded problem for the system solution. Before the proof we need preparation.
Definition 2. ([31]) The solution of System (1.1) is called stochastically ultimately bounded, for any ε∈(0,1) if there exists a constant H=H(ε) such that for any initial value W0=(x0,y0,z0) in R3+, the solution W(t)=(x(t),y(t),z(t)) of System (1.1) has the property that
lim supt→∞P{|W(t)|>H}<ε. |
Theorem 4. The solution of System (1.1) is stochastically ultimately bounded for any initial value W0=(x0,y0,z0) in R3+.
Proof. First, define a function V:R3+→R+
V21(x,y,z)=x2+y2+z2+(m+x+y)z2≜V1(x,y,z)+V2(x,y,z). |
By Itô's formula, we can get
dV21(x(t),y(t),z(t))=LV21(x(t),y(t),z(t))dt+[σ1x(t)dB1(t)+σ2y(t)dB2(t)]z2+(m+x+y)[2z2σ3dB3(t)]+2σ1x2dB1(t)+2σ2y2dB2(t)+2σ3z2dB3(t). |
So we have
LV1(x,y,z)≤2x(rx−bx2)+σ21x2+2y(ηy−cy2)+σ23y2+2βz2+σ22z2 | (4.2) |
and
LV2(x,y,z)=[m+rx(θ+K(1−θ)K+z)−bx2−ax(t)z(t)1+b1(x(t)+y(t))+b2z(t)−ηx(t)y(t)b3+x(t)+ηx(t)y(t)b3+x(t)−cy2(t)−dy(t)z(t)1+b1(x(t)+y(t))+b2z(t)−γy(t)]z2+2(m+x+y)z2(β−gzm+x+y)+σ23(m+x+y)z2. | (4.3) |
Rectifying (4.2) and (4.3) yields
LV21(x,y,z)≤[m+rx−bx2−cy2−γy]z2+2(m+x+y)βz2−2gz3+σ23(m+x+y)z2+(2r+σ21)x2−2bx3+(2η+σ22)y2−2cy3+(2β+σ23)z2=[m+rx−bx2−cy2−γy+(2β+σ23)(m+x+y)]z2−2gz3+(2r+σ21)x2−2bx3+(2η+σ22)y2−2cy3+(2β+σ23)z2. | (4.4) |
Define the function
R(t)=etV21(x,y,z); |
we can obtain
LR=et(V21+LV21)≤et{(m+x+y)z2+[m+rx−bx2−cy2−γy+(2β+σ23)(m+x+y)]z2−2gz3+(2r+σ21)x2−2bx3+(2η+σ22)y2−2cy3+(2β+σ23)z2}. | (4.5) |
From the above equation we can obtain that there exists a positive number G such that LW≤Get. Therefore integrating both sides of (4.5) from 0 to t gives
R(t)≤R(0)+G(et−1)+∫t0et{(m+x+y)[2z2σ3dB(t)]+2σ1x2dB(t)+2σ2y2dB(t)+2σ3z2dB(t)}ds. | (4.6) |
Then, the expectations are taken at both ends of (4.6), so the following results can be obtained
E(et{(m+x+y)z2+x2+y2+z2})≤R(0)+G(et−1). |
Therefore, we have
E|W(t)|2=E(x2+y2+z2)≤e−tR(0)+G(1−e−t)≜G1. |
Using Chebyshev inequality, we obtain
P{|W(t)|>H}≤E|W(t)|2H2. | (4.7) |
Next, taking the upper limit of (4.7) gives
lim supt→∞P{|W(t)|>H}≤G1H2=ε2<ε, a.s. |
where ε∈(0,1) and H=2√2G1ε.
The conclusion is confirmed.
Let X(t) be a homogeneous Markov process in Eh (Eh denotes Euclidean h-space) described by the stochastic equation
dX(t)=g(X)dt+l∑ψ=1σψdBu(t). |
The diffusion matrix is given as follows:
Φ(x)=(aij(x)), aij(x)=l∑ψ=1σiψσjψ. |
If there exists a bounded domain U⊂Eh with a regular boundary, then the following lemma holds:
Lemma 4. ([32]) The Markov process X(t) has a unique stationary distribution ς(⋅) if it satisfies the following conditions:
(A.1):Suppose a positive number M makes ∑di,j=1aij(x)ζiζj≥M|ζ|2, x∈U, ξ∈Rd.
(A.2):There exists a C2−function such that LV is negative for ∀R3+∖U. Then we have
P{limT→∞1T∫T0f(X(t))dt=∫Ehf(x)μ(dx)}=1 |
for ∀x∈Eh, where f(⋅) is a function integrable with respect to the measure ς.
To verify the condition (A.2), it is necessary to prove that there exist a neighborhood U and a nonnegative function V(x,y,z) such that LV is negative for any Eh∖U.
Lemma 5. ([33]) For ∀s>0, the following inequality holds:
s(1−s)+2s≤2√s. | (4.8) |
Theorem 5. According to Lemma 4, for any initial value (x0,y0,z0), there exists an ergodic stationary distribution for System (4.1) if the following conditions hold.
b2η(r−σ212−ab2)2r(b3b+1)(b+1)2−(γ+db2+σ222)>0, 2db2+2γ+σ22−η<0, σ232−β<0,c2γ−η2γ(c+2bηr(b+1)√Aηr2b)>0, and 3b−η2γ(c+2bηr(b+1)√Aηr2b)>0. |
Proof. Now we prove the condition (A.2). According to the inequality b(x−rb)2>0, we derive
L(x)≤rx−bx2≤−r(b3+x)+rb3+r2b. |
Define V11(x,y)=−lny+Ax, where A is a positive constant which will be determined later; we have
LV11(x,y)=−ηxb3+x+cy+dz1+b1(x+y)+b2z+γ+σ222−Ar(b3+x)+A(rb3+r2b)≤−2√ηAr⋅√x+γ+σ222+A(rb3+r2b)+db2+cy. | (4.9) |
Then define V12=b2r2x+br(b+1)(−lnx) and use Lemma 5; we can obtain
LV12(x,y)≤b2r2[rx(θ+K(1−θ)1+z)−bx2]+brx−br(b+1)(r−σ212−ab2)+bηyr(b+1)≤√br⋅√x−br(b+1)(r−σ212−ab2)+bηyr(b+1). | (4.10) |
Next, we define V13(x,y)=V11(x,y)+2√Aηr2bV12(x,y)+1γ(c+2bnr(b+1)√Aηr2b)y. Combining (4.9) and (4.10), we have the following inequality
LV13(x,y)≤−2√ηAr⋅√x+γ+σ222+A(rb3+rb)+db2+cy+2√Aηr2b[√br⋅√x−br(b+1)(r−σ212−ab2)+bηyr(b+1)]+(ηxyb3+x−cy2−γy)1γ(c+2bηr(b+1)√Aηr2b)≤−2br(b+1)(r−σ212−ab2)√Aηr2b+γ+σ222+db2+A(rb3+rb)+ηγ(c+2bηr(b+1)√Aηr2b)xy−c2γy2. | (4.11) |
Choose
A=b3η(r−σ212−ab2)2r2(b3b+1)2(b+1)2. |
So we have
LV13(x,y)≤−b2η(r−σ212−ab2)2r(b3b+1)(b+1)2+db2+γ+σ222+ηγ(c+2bηr(b+1)√Aηr2b)xy−c2γy2≜−B+ηγ(c+2bηr(b+1)√Aηr2b)xy−c2γy2≤−B+η2γ(c+2bηr(b+1)√Aηr2b)x2−[c2γ−η2γ(c+2bηr(b+1)√Aηr2b)]y2, | (4.12) |
where B=b2η(r−σ212−ab2)2r(b3b+1)(b+1)2−(γ+db2+σ222)>0.
In the next step, we make
V14(x,y,z)=(y−i+z−i) |
and i∈(0,1) is a positive number. By Itô's formula, we have
LV14=−iy−i[ηxb3+x−cy−dz1+b1(x+y)+b2z−γ−(1+i)σ222]−iz−i[β−gzm+x+y−(1+i)σ232]≤iy−ix(db2+γ+(1+i)σ222−η)+b3(db2+γ+(1+i)σ222)b3+x+iz−i[(1+i)σ232−β]+icy1−i+igmz1−i≤i(2db2+2γ+(1+i)σ22−η)y−i+iz−i[(1+i)σ232−β]+icy1−i+igmz1−i. | (4.13) |
Let us choose i sufficiently small such that
2db2+2γ+(1+i)σ22−η<0, (1+i)σ232−β<0. |
Finally, we define the function V15=RV13+V14+3Rx+(m+x+y)z2, where R is a positive constant satisfying −RB+fu1+fu2+fu3=−2, in which fu1,fu2 and fu3 are bounded functions on [0,∞) and fui=supt≥0fi(t) (i=1,2,3); it will be determined later.
According to (4.3), we can obtain
LV15≤−RB+i(2db2+2γ+(1+i)σ22−η)y−i−R[c2γ−η2γ(c+2bηr(b+1)√Aηr2b)]y2−R[3b−η2γ(c+2bηr(b+1)√Aηr2b)]x2+iz−i[(1+i)σ232−β]+icy1−i+igmz1−i−2gz3+3Rrx+[m+rx−bx2+ηy−cy2+(m+x+y)(σ23+2β)]z2=f1+f2+f3−RB, | (4.14) |
where
f1=−R[c2γ−η2γ(c+2bηr(b+1)√Aηr2b)]y2+i(2db2+2γ+(1+i)σ22−η)y−i+icy1−i,f2=−2gz3+[m+rx−bx2+ηy−cy2+(m+x+y)(σ23+2β)]z2+iz−i[(1+i)σ232−β]+igmz1−i,f3=3Rrx−R[3b−η2γ(c+2bηr(b+1)√Aηr2b)]x2. |
With the condition that c2γ−η2γ(c+2bηr(b+1)√Aηr2b)>0, 2b−η2γ(c+2bηr(b+1)√Aηr2b)>0. Denote
Σ(x,y,z)=f1+f2+f3−RB. |
Then we have
Σ(x,y,z)≤{Σ(+∞,y,z)→−∞, as x→+∞,Σ(x,+∞,z)→−∞, as y→+∞,Σ(x,y,+∞)→−∞, as z→+∞,−RB+fu1+fu2++fu3≤−2, as x→0+, y→0+ or z→0+. | (4.15) |
Therefore, we can deduce that
LV15(x,y,z)≤−1 | (4.16) |
for ∀(x,y,z)∈R3+∖U, which implies that the condition (A.2) in Lemma 4 is satisfied.
The next step will be to prove the condition (A.1) and the following is the diffusion matrix of the System (4.1):
˜A(x;y;z)=(σ21x2000σ22y2000σ23z2). |
Choose ˜M=minx,y,z∈U⊂R+3{σ21x2,σ22y2,σ23z2} such that
σ21x2ζ21+σ22y2ζ22+σ23z2ζ23≥˜M|ζ2|, for all (x,y,z)∈U, ζ∈R3. |
Therefore we can conclude that the condition (A.1) in Lemma 4 holds. Further, from Lemma 4, we can infer that System (4.1) is ergodic and has a unique stationary distribution.
In this section, to verify the conditions obtained by theorems, we take the determined initial values x0=2.9, y0=1.4 and z0=0.5 for the numerical simulation of System (1.1). In addition, let σ1=σ2=σ3=0.6 and γ1=γ2=γ3=0.06. The figures for the numerical simulations are as follows, where the left figure shows the numerical simulation of the stochastic model with white noise and Lévy noise, and the right figure shows the numerical simulation of the deterministic model.
Example 1.
As shown on the left in Figure 1, in order to verify the case of extinction of both the predator and prey populations in Theorem 2, we chose the appropriate parameters r=0.1,θ=0.09,K=0.35,b=0.8,a=0.27,b1=0.16,b2=0.5, η=0.015,b3=0.08,c=0.08,d=0.004,γ=0.06,β=0.013,g=0.01,m=0.01, σ1=σ2=σ3=0.6 and Γ1=Γ2=Γ3=0.06; then, we have 0.1×(0.09+0.35×0.01)−0.622−∫Γ[0.06−ln(1+0.06)]λ(du)≈−0.172<0, 0.015−0.622−∫Γ[0.06−ln(1+0.06)]λ(du)≈−0.003<0 and 0.13−0.622−∫Γ[0.06−ln(1+0.06)]λ(du)≈−0.168<0. In this case, the populations of x(t),y(t) and z(t) all tend to become extinct, in accordance with the conclusion obtained in Theorem 2. Compared to the graph on the right, the curve of the stochastic model converges to zero with sharp fluctuations, while the curve of the deterministic model is smooth and takes longer to converge to zero. This shows that random factors accelerate the rate of population extinction when the conditions of Theorem 2 hold.
Example 2.
When 0.015−0.622−∫Γ[0.06−ln(1+0.06)]λ(du)≈−0.003<0, the infected prey population tends to become extinct. This is illustrated in Figures 2–4.
In order to verify the conditions of (A1) in Theorem 3, the numerical simulation we made by selecting suitable parameters is shown in Figure 2. Figure 2 shows that when r=0.1,θ=0.09,K=0.35,b=0.8,a=0.27,b1=0.16,b2=0.5,η=0.015,b3=0.08, c=0.08,d=0.004,γ=0.06,β=0.38,g=0.01,m=0.01, σ1=σ2=σ3=0.6 and Γ1=Γ2=Γ3=0.06; then, we have 0.1−0.622−∫Γ[0.06−ln(1+0.06)]λ(du)≈−0.08<0, 0.015−0.622−∫Γ[0.06−ln(1+0.06)]λ(du)≈−0.003<0 and 0.38−0.622−∫Γ[0.06−ln(1+0.06)]λ(du)≈0.199>0. At this time, susceptible and infected prey populations x(t) and y(t) tend to become extinct and predator populations y(t) tend to persist. Compared to the deterministic model, the left curve with the effect of white noise and Levy noise changes more dramatically.
In order to verify the conditions of (A2) in Theorem 3, the numerical simulation we made by selecting suitable parameters is shown in Figure 3. We chose r=21.45 and β=0.01 and the other parameters take the same value. Then we have 21.45−0.622−∫Γ[0.06−ln(1+0.06)]λ(du)>0 and 0.01−0.622−∫Γ[0.06−ln(1+0.06)]λ(du)<0. At this point, as seen in Figure 3, susceptible prey populations tend to persist and predator populations tend to become extinct. Whereas in the right picture, x(t) is gradually leveling off and z(t) is not extinct, but slowly rising.
In order to verify the conditions of (A3) in Theorem 3, the numerical simulation we made by selecting suitable parameters is shown in Figure 4. We set r=21.45 and β=0.19 and the other parameters take the same value. Then we have 21.45−0.622−∫Γ[0.06−ln(1+0.06)]λ(du)>0 and 0.19−0.622−∫Γ[0.06−ln(1+0.06)]λ(du)>0. From Figure 3, we can see that both the susceptible prey populations and predator populations tend to be persistent. This satisfies the condition given by (A3) in Theorem 3. z(t) grows more rapidly in the deterministic model than in the model with white noise versus Lévy noise.
Example 3.
To verify the condition of Theorem 5 that System (1.1) has an ergodic stationary distribution, we chose the following parameter values: r=18,θ=0.09,K=0.35,b=0.8,a=0.27,b1=0.16,b2=4.6,η=0.78, b3=0.18,c=0.7,d=0.004,γ=0.19,β=0.65,g=0.012 and m=0.012. From the conditions obtained in Theorem 5, it follows that η2γ(c+2bηr(b+1)√Aηr2b)≈1.863<c2γ≈2.579, η2γ(c+2bηr(b+1)√Aηr2b)≈1.863<3b=2.4, b2η(r−σ212−ab2)2r(b3b+1)(b+1)2≈2.360>γ+db2+σ222=0.37, 2db2+2γ+σ22≈0.741<η=0.78 and σ232=0.18<0.65. As shown in Figure 5, the sample paths are concentrated within regions of circularity or ellipticity, which indicates that the system is stochastically stable.
This paper discusses the dynamical properties of predator-prey models with fear effects and disease transmission in prey population. Meanwhile, susceptible prey populations, infected prey populations and predator populations are affected by white noise and Lévy noise. By constructing the appropriate Lyapunov equation, we proved the uniqueness of the global positive solution of System (1.1). From Theorem 2, it is clear that under certain conditions, Lévy noise can lead to population extinction. Furthermore, the fear effect can also lead to population size change. When the fear effect is too large, it is more likely to result in population extinction. We also explored the existence and extinction of susceptible prey populations and predator populations under conditions when infectious diseases prevalent among prey populations are effectively prevented and infected prey populations die out in Theorem 3. Then, we studied the stochastic ultimate boundedness of System (4.1) and the ergodic stationary distribution under certain conditions without the influence of Lévy noise. Finally, the numerical simulations were performed at the end to further illustrate the validity of the theoretical results. Adding the influence of environmental factors to the model made it more consistent with the predator-prey relationship in the ecosystem. This shows that stochastic factors have an effect on the behavior of population dynamics and in some cases can accelerate the extinction of populations. The fear effect also affects the population size change; when the fear effect is stronger, the population is more likely to become extinct.
This research was supported by the Natural Science Foundation of Heilongjiang Province (No. LH2022A002, No. LH2021A018), National Natural Science Foundation of China (No. 12071115) and Fundamental Research Funds for the Central Universities (No. 2572020BC09).
The authors declare that there is no conflict of interest.
[1] | J. A. Pedras-Vasconcelos, The Immunogenicity of Therapeutic Proteins-What you Don't Know Can Hurt YOU and the Patient. SBIA REdI Fall, Ed.; U.S. Food and Drug Administration: Silver Spring, MD, USA, 2014. Available from: https://www.fda.gov/files/drugs/published/The-immunogenicity-of-therapeutic-proteins--what-you-don%E2%80%99t-know-can-hurt-YOU-and-the-patient--Fall-2014.pdf. |
[2] | J. M. Carton, W. R. Strohl, Chapter 4-Protein therapeutics (introduction to biopharmaceuticals), Intro. Biol. Small Mole. Drug Rese. Develop., (2013), 127-159. |
[3] |
N. Chirmule, V. Jawa, B. Meibohm, Immunogenicity to therapeutic proteins: Impact on PK/PD and Efficacy, AAPS J., 14 (2012), 296-302. doi: 10.1208/s12248-012-9340-y
![]() |
[4] |
K. D. Ratanji, J. P. Derrick, R. J. Dearman, et al. Immunogenicity of therapeutic proteins: Influence of aggregation, J. Immunotoxicol, 11 (2014), 99-109. doi: 10.3109/1547691X.2013.821564
![]() |
[5] | A. Kuriakose, N. Chirmule, P. Nair, Immunogenicity of biotherapeutics: Causes and association with posttranslational modifications, J. Immunol. Res., 2016 (2016), 1-18. |
[6] |
S. Tourdot, T. P. Hickling, Nonclinical immunogenicity risk assessment of therapeutic proteins, Bioanalysis, 11 (2019), 1631-1643. doi: 10.4155/bio-2018-0246
![]() |
[7] |
G. Shankar, S. Arkin, L. Cocea, et al. Assessment and reporting of the clinical immunogenicity of therapeutic proteins and peptides-harmonized terminology and tactical recommendations, AAPS J., 16 (2014), 658-673. doi: 10.1208/s12248-014-9599-2
![]() |
[8] |
B. Chen, J. Q. Dong, W. J. Pan, et al. Pharmacokinetics/pharmacodynamics model supported early drug development, Curr Pharm Biotechnol., 13 (2012), 1360-1375. doi: 10.2174/138920112800624436
![]() |
[9] | A. Smith, H. Manoli, S. Jaw, et al. Unraveling the effect of immunogenicity on the PK/PD, efficacy, and safety of therapeutic proteins, J. Immunol. Res., 2016 (2016), 1-9. |
[10] | W. H. Boehncke, N. C. Brembilla, Immunogenicity of biologic therapies: Causes and consequences, Exp. Rev. Clin. Immunol., 14 (2018), 513-523. |
[11] | B. W. Neun, Y. Barenholz, J. Szebeni, et al. Understanding the Role of Anti-PEG Antibodies in the Complement Activation by Doxil in Vitro, Molecule, 23 (2018), 1700. |
[12] | S. Kathman, T. M. Thway, L. Zhou, et al. Utility of a bayesian mathematical model to predict the impact of immunogenicity on pharmacokinetics of therapeutic proteins, AAPS J., 18 (2016), 424. |
[13] |
E. M. J. van Brummelen, W. Ros, G. Wolbink, et al. Antidrug antibody formation in oncology: Clinical relevance and challenges, Oncologist, 21 (2016), 1260-1268. doi: 10.1634/theoncologist.2016-0061
![]() |
[14] | S. Gupta, S. R. Indelicato, V. Jethwa, et al. Recommendations for the design, optimization, and qualification of Cell-Based assays used for the detection of neutralizing antibody responses elicited to biologycal therapeutics, J. Immunol. Methods, 32 (2007), 1-18. |
[15] | X. Chen, T. P. Hickling, P. Vicini, A mechanistic, multiscale mathematical model of immunogenicity for therapeutic proteins: Part 1-Theoretical model, CPT Pharmacometrics Syst. Pharmacol., 3 (2014), e133. |
[16] | L. Hamuro, G. S. Tirucherai, S. M. Crawford, et al. Evaluating a multiscale mechanistic model of the immune system to predict human immunogenicity for a biotherapeutic in Phase 1, AAPS J., 21 (2019), 94. |
[17] |
G. I. Bell, Mathematical model of clonal selection and antibody production, J Theor Biol., 29 (1970), 191-232. doi: 10.1016/0022-5193(70)90019-6
![]() |
[18] |
H. Y. Lee, D. J. Topham, S. Y. Park, et al. Simulation and prediction of the adaptive immune response to influenza a virus infection, J. Virol., 83 (2009), 7151-7165. doi: 10.1128/JVI.00098-09
![]() |
[19] |
Z. H. Xu, H. Lee, T. Vu, et al. Populations pharmacokinetics of golimumab in patients with anklosing spondylitis: Impact of body weight and immunogenicity, Int J Clin Pharmacol Ther., 48 (2010), 596-607. doi: 10.5414/CPP48596
![]() |
[20] | P. L. Bonate, C. Sung, K. Welch, et al. Conditional modeling of antibody titers using A Zero-Inflated poisson random effect model: Application to fabrazyme, J Pharmacokinet Phar., 35 (2009), 449-459. |
[21] |
X. Chen, T. P. Hickling, E. Kraynov, et al. A mathematical model of the effect of immunogenicity on therapeutic protein pharmacokinetics, AAPS J., 15 (2013), 1141-1154. doi: 10.1208/s12248-013-9517-z
![]() |
[22] |
J. Foote, C. Milstein, Kinetic maturation of an immune response, Nature, 352 (1991), 530-532. doi: 10.1038/352530a0
![]() |
[23] | B. S. Alexandra, N. Radhika, H. Paul, Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies, Chapter 9-Biobetter Biologics, New York: Academic Press, (2015), 199-217. |
[24] | Pacific Immunology, Learning Center: Antibody Affinity and Affinity Maturation, 2020., Available from: https://www.pacificimmunology.com/resources/antibody-introduction/antibody-affinity-and-affinity-maturation/. |
[25] | S. Yi, P. W. Nelson, A. G. Ulsoy, Time-delay sistems: Analysis and control using the Lambert W function, World Scientific, Singapore, 2010. |
[26] | Kasbawati, A. Y. Gunawan, R. Hertadi, et al. Effects of time delay on the dynamics of a kinetic model of a microbial fermentation process, ANZIAM J., 55 (2014), 336-356. |
[27] | J. D. Murray, (1990) Mathematical biology, 2Eds., New York: Springer. |
[28] |
L. F. Shampine, S. Thompson, Solving DDEs in MATLAB, Appl. Numer. Math. 37 (2001), 441-458. doi: 10.1016/S0168-9274(00)00055-6
![]() |
1. | Carla Kuesten, Jennifer Dang, Miki Nakagawa, Jian Bi, Herbert L. Meiselman, Japanese consumer segmentation based on general self-efficacy psychographics data collected in a phytonutrient supplement study: Influence on health behaviors, well-being, product involvement and liking, 2022, 99, 09503293, 104545, 10.1016/j.foodqual.2022.104545 |